Ameritas Investment Partners’s CASI Pharmaceuticals CASI Stock Holding History

Ameritas Investment Partners’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-435	Closed	-$10K	–	3079
2021 Q1	$10K	Hold	435	–	–	﹤0.01%	2848
2020 Q4	$13K	Hold	435	–	–	﹤0.01%	2672
2020 Q3	$7K	Hold	435	–	–	﹤0.01%	2860
2020 Q2	$11K	Hold	435	–	–	﹤0.01%	2661
2020 Q1	$9K	Hold	435	–	–	﹤0.01%	2586
2019 Q4	$13K	Hold	435	–	–	﹤0.01%	2622
2019 Q3	$15K	Hold	435	–	–	﹤0.01%	2533
2019 Q2	$14K	Hold	435	–	–	﹤0.01%	2635
2019 Q1	$12K	Hold	435	–	–	﹤0.01%	2623
2018 Q4	$17K	Hold	435	–	–	﹤0.01%	2427
2018 Q3	$20K	Hold	435	–	–	﹤0.01%	2499
2018 Q2	$36K	Buy	+435	New	+$29.4K	﹤0.01%	2183

Other funds holding CASI

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's CASI Position: Q2 2021 in Review

Ameritas Investment Partners sold out of CASI Pharmaceuticals (CASI) in Q2 2021, closing a stake of 435 shares — an estimated $10K sold.

Ameritas Investment Partners first reported a position in CASI in Q2 2018 and held it in 12 quarters. The position peaked at $36K in Q2 2018. 68 funds tracked by Wall St. Rank hold CASI as of Q2 2021.

Ameritas Investment Partners reported no remaining CASI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 435 CASI Pharmaceuticals shares in Q2 2021, an estimated $10K.
Ameritas Investment Partners first reported a position in CASI Pharmaceuticals in Q2 2018 and held it in 12 quarters.
Ameritas Investment Partners's CASI Pharmaceuticals position peaked at $36K in Q2 2018.
68 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.